Tais Mendes Camargo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tais Mendes Camargo has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Augusto Lima Marson
LunGuardian Research Group—Epidemiology of Respiratory and Infectious Diseases, São Francisco University
4 shared publications - Rodrigo Marques Tonella
Federal University of Minas Gerais, Brazil
4 shared publications - Aline Guizzi Parisi
Universidade São Francisco – USF. Bragança Paulista/SP, Brasil
2 shared publications - André Cabral Sardim
Universidade São Francisco
2 shared publications - Arieli Cristina Magalhães
Universidade São Francisco – USF. Bragança Paulista/SP, Brasil
2 shared publications - Arthur Nunes Marche
Universidade Federal de São Carlos – UFSCar. São Carlos/SP, Brasil
2 shared publications
Latest Publications
- Open Access
- 5 May 2026
- Published by Wiley in Diabetic Medicine
- p. e70349
The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic
Aims: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality. In this context, this study aims to analyse the epidemiological profile of hospitalized people with diabetes mellitus and COVID‐19 in Brazil over 4 years of the pandemic. Methods: The epidemiological analysis was conducted using data from the Open‐Data‐SUS ( Sistema Único de Saúde , Brazilian Unified Health System) platform (Brazilian Ministry of Health) covering the period from March 2020 to March 2024. Data were processed in Statistical Package for the Social Sciences software, with missing values imputed using XLSTAT. Variables included demographic profile, viral infection, co‐morbidities, clinical signs and symptoms, intensive care unit (ICU) admission and mechanical ventilation, and outcomes. Statistical analyses comprised bivariate and multivariable logistic regression with a 5% significance level, focusing on two primary comparisons: the risk of death and the likelihood of classification as diabetes mellitus. The study protocol was approved by the institutional ethics committee. Results: Among 2,078,062 people hospitalized with SARS‐CoV‐2 in Brazil, 22.2% ( N = 461,647) had diabetes mellitus, with marked regional heterogeneity in both prevalence and mortality. Overall mortality was 32.9% ( N = 683,088). Diabetes mellitus was not only highly prevalent but also emerged as an independent risk factor for in‐hospital death, significantly increasing mortality odds (OR = 1.178; 95% confidence interval [95% CI] = 1.168–1.188), as well as higher likelihood of ICU admission (OR = 1.102; 95% CI = 1.093–1.112) and invasive mechanical ventilation (OR = 1.102; 95% CI = 1.087–1.118). Older age, female sex and self‐identification as Black, mixed‐race or Asian were also strongly associated with diabetes mellitus. The presence of co‐morbidities, such as cardiopathy (heart disease), kidney disease, obesity, liver disease, and neurological disorders further amplified the risk of poor outcomes. Regarding vaccination, most people were unvaccinated, and while COVID‐19 vaccination showed a modest association with DM diagnosis, it consistently reduced the risk of death (OR = 0.588; 95% CI = 0.583–0.594). Conversely, nosocomial infection substantially increased mortality risk, despite presenting a divergent pattern in relation to diabetes mellitus in adjusted models. Clinical symptoms most strongly associated with death included dyspnoea, respiratory discomfort and peripheral oxygen saturation below 95%. Hospital management variables were decisive: ICU admission and ventilatory support, especially invasive mechanical ventilation (OR = 12.933; 95% CI = 12.752–13.115), markedly increased mortality. Overall, advanced age remained the strongest predictor, with individuals older than 85 years experiencing more than a 30‐fold increased risk of death compared with younger groups (OR = 32.840; 95% CI = 30.840–34.969). Conclusions: Diabetes mellitus is an independent predictor of worse outcomes in hospitalized people with COVID‐19 in Brazil. Mortality is strongly influenced by age, co‐morbidities and severity markers, while vaccination provides substantial protection.
- 5 May 2026
- Published by Wiley in Diabetic Medicine
- p. e70349
Open AccessThe burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic
Aims: Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality. In this context, this study aims to analyse the epidemiological profile of hospitalized people with diabetes mellitus and COVID‐19 in Brazil over 4 years of the pandemic. Methods: The epidemiological analysis was conducted using data from the Open‐Data‐SUS ( Sistema Único de Saúde , Brazilian Unified Health System) platform (Brazilian Ministry of Health) covering the period from March 2020 to March 2024. Data were processed in Statistical Package for the Social Sciences software, with missing values imputed using XLSTAT. Variables included demographic profile, viral infection, co‐morbidities, clinical signs and symptoms, intensive care unit (ICU) admission and mechanical ventilation, and outcomes. Statistical analyses comprised bivariate and multivariable logistic regression with a 5% significance level, focusing on two primary comparisons: the risk of death and the likelihood of classification as diabetes mellitus. The study protocol was approved by the institutional ethics committee. Results: Among 2,078,062 people hospitalized with SARS‐CoV‐2 in Brazil, 22.2% ( N = 461,647) had diabetes mellitus, with marked regional heterogeneity in both prevalence and mortality. Overall mortality was 32.9% ( N = 683,088). Diabetes mellitus was not only highly prevalent but also emerged as an independent risk factor for in‐hospital death, significantly increasing mortality odds (OR = 1.178; 95% confidence interval [95% CI] = 1.168–1.188), as well as higher likelihood of ICU admission (OR = 1.102; 95% CI = 1.093–1.112) and invasive mechanical ventilation (OR = 1.102; 95% CI = 1.087–1.118). Older age, female sex and self‐identification as Black, mixed‐race or Asian were also strongly associated with diabetes mellitus. The presence of co‐morbidities, such as cardiopathy (heart disease), kidney disease, obesity, liver disease, and neurological disorders further amplified the risk of poor outcomes. Regarding vaccination, most people were unvaccinated, and while COVID‐19 vaccination showed a modest association with DM diagnosis, it consistently reduced the risk of death (OR = 0.588; 95% CI = 0.583–0.594). Conversely, nosocomial infection substantially increased mortality risk, despite presenting a divergent pattern in relation to diabetes mellitus in adjusted models. Clinical symptoms most strongly associated with death included dyspnoea, respiratory discomfort and peripheral oxygen saturation below 95%. Hospital management variables were decisive: ICU admission and ventilatory support, especially invasive mechanical ventilation (OR = 12.933; 95% CI = 12.752–13.115), markedly increased mortality. Overall, advanced age remained the strongest predictor, with individuals older than 85 years experiencing more than a 30‐fold increased risk of death compared with younger groups (OR = 32.840; 95% CI = 30.840–34.969). Conclusions: Diabetes mellitus is an independent predictor of worse outcomes in hospitalized people with COVID‐19 in Brazil. Mortality is strongly influenced by age, co‐morbidities and severity markers, while vaccination provides substantial protection.
- Open Access
- 16 October 2025
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 49
Functional performance analysis in individuals recovered from COVID-19: assessment through the six-minute walk test
The COVID-19 pandemic has posed significant challenges to healthcare systems, with physiotherapy playing a crucial role in the management of post-infection patients. This descriptive study investigated the Six-Minute Walk Test (6MWT) as an assessment tool to monitor physiological and functional changes in post-COVID patients. Conducted at the Outpatient Clinic of Physiotherapy in Cardiology and Pulmonology at Universidade São Francisco, Bragança Paulista/SP, the study included 18 individuals referred for pulmonary rehabilitation, with a median age of 47 years (±13.40), body mass of 74.50 kg (±20.48), and mean height of 1.65 m (±0.09). The median distance covered in the 6MWT was 481 meters (±106.20), corresponding to 78.9% of the predicted value according to the guidelines of the American Thoracic Society and the European Respiratory Society, indicating reduced tolerance to submaximal aerobic exercise. Statistically significant differences were observed between initial and final values of systolic blood pressure (p < 0.005), heart rate (p < 0.002), rate-pressure product (p < 0.001), and Borg’s Rating of Perceived Exertion scale, both respiratory (p < 0.006) and muscular (p < 0.007). However, no significant differences were found in oxygen saturation (p > 0.34) or diastolic blood pressure (p > 1.00). The results suggest that cardiovascular and hemodynamic adjustments occurred physiologically, reinforcing the use of the 6MWT as a valuable tool for assessing submaximal functional capacity and physiological responses to exercise. The 6MWT proved to be useful in evaluating exercise tolerance in post-COVID individuals.
- 16 October 2025
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 49
Open AccessFunctional performance analysis in individuals recovered from COVID-19: assessment through the six-minute walk test
The COVID-19 pandemic has posed significant challenges to healthcare systems, with physiotherapy playing a crucial role in the management of post-infection patients. This descriptive study investigated the Six-Minute Walk Test (6MWT) as an assessment tool to monitor physiological and functional changes in post-COVID patients. Conducted at the Outpatient Clinic of Physiotherapy in Cardiology and Pulmonology at Universidade São Francisco, Bragança Paulista/SP, the study included 18 individuals referred for pulmonary rehabilitation, with a median age of 47 years (±13.40), body mass of 74.50 kg (±20.48), and mean height of 1.65 m (±0.09). The median distance covered in the 6MWT was 481 meters (±106.20), corresponding to 78.9% of the predicted value according to the guidelines of the American Thoracic Society and the European Respiratory Society, indicating reduced tolerance to submaximal aerobic exercise. Statistically significant differences were observed between initial and final values of systolic blood pressure (p < 0.005), heart rate (p < 0.002), rate-pressure product (p < 0.001), and Borg’s Rating of Perceived Exertion scale, both respiratory (p < 0.006) and muscular (p < 0.007). However, no significant differences were found in oxygen saturation (p > 0.34) or diastolic blood pressure (p > 1.00). The results suggest that cardiovascular and hemodynamic adjustments occurred physiologically, reinforcing the use of the 6MWT as a valuable tool for assessing submaximal functional capacity and physiological responses to exercise. The 6MWT proved to be useful in evaluating exercise tolerance in post-COVID individuals.
- Open Access
- 16 October 2025
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 49
Análise do desempenho funcional em indivíduos recuperados da COVID-19: avaliação por meio do teste de caminhada de seis minutos
A pandemia de COVID-19 trouxe desafios significativos aos sistemas de saúde, com a fisioterapia desempenhando papel crucial no manejo de pacientes pós-infecção. Este estudo descritivo investigou o Teste de Caminhada de Seis Minutos (TC6’) como ferramenta de avaliação para monitorar alterações fisiológicas e funcionais em pacientes pós-COVID. Realizado no Ambulatório de Fisioterapia em Cardiologia e pneumologia da Universidade São Francisco, em Bragança Paulista/SP, incluiu 18 indivíduos com encaminhamento para reabilitação pulmonar, com idade mediana de 47 anos (±13,40), massa corporal de 74,50 kg (±20,48) e estatura média de 1,65 m (±0,09). A distância mediana percorrida no TC6’ foi de 481 metros (±106,20), correspondendo a 78,9% do valor previsto segundo as diretrizes da American Thoracic Society e European Respiratory Society, indicando redução da tolerância ao exercício aeróbico submáximo. Diferenças estatisticamente significativas foram observadas entre os valores iniciais e finais da pressão arterial sistólica (p < 0,005), frequência cardíaca (p < 0,002), duplo produto (p < 0,001) e escala de percepção subjetiva de BORG, tanto respiratório (p < 0,006) quanto muscular (p < 0,007). Contudo, não foram identificadas diferenças na saturação de oxigênio (p > 0,34) e na pressão arterial diastólica (p > 1,00). Os resultados sugerem que ajustes cardiovasculares e hemodinâmicos ocorreram de forma fisiológica, reforçando o uso do TC6’ como instrumento valioso para avaliar a capacidade funcional submáxima e a resposta fisiológica ao exercício. O TC6’ demonstrou-se útil na avaliação da tolerância ao esforço em indivíduos pós-COVID.
- 16 October 2025
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 49
Open AccessAnálise do desempenho funcional em indivíduos recuperados da COVID-19: avaliação por meio do teste de caminhada de seis minutos
A pandemia de COVID-19 trouxe desafios significativos aos sistemas de saúde, com a fisioterapia desempenhando papel crucial no manejo de pacientes pós-infecção. Este estudo descritivo investigou o Teste de Caminhada de Seis Minutos (TC6’) como ferramenta de avaliação para monitorar alterações fisiológicas e funcionais em pacientes pós-COVID. Realizado no Ambulatório de Fisioterapia em Cardiologia e pneumologia da Universidade São Francisco, em Bragança Paulista/SP, incluiu 18 indivíduos com encaminhamento para reabilitação pulmonar, com idade mediana de 47 anos (±13,40), massa corporal de 74,50 kg (±20,48) e estatura média de 1,65 m (±0,09). A distância mediana percorrida no TC6’ foi de 481 metros (±106,20), correspondendo a 78,9% do valor previsto segundo as diretrizes da American Thoracic Society e European Respiratory Society, indicando redução da tolerância ao exercício aeróbico submáximo. Diferenças estatisticamente significativas foram observadas entre os valores iniciais e finais da pressão arterial sistólica (p < 0,005), frequência cardíaca (p < 0,002), duplo produto (p < 0,001) e escala de percepção subjetiva de BORG, tanto respiratório (p < 0,006) quanto muscular (p < 0,007). Contudo, não foram identificadas diferenças na saturação de oxigênio (p > 0,34) e na pressão arterial diastólica (p > 1,00). Os resultados sugerem que ajustes cardiovasculares e hemodinâmicos ocorreram de forma fisiológica, reforçando o uso do TC6’ como instrumento valioso para avaliar a capacidade funcional submáxima e a resposta fisiológica ao exercício. O TC6’ demonstrou-se útil na avaliação da tolerância ao esforço em indivíduos pós-COVID.
- Open Access
- 20 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 5919
MicroRNA-Mediated Regulation of Vascular Endothelium: From Pro-Inflammation to Atherosclerosis
Endothelial inflammation and atherosclerosis remain leading drivers of cardiovascular disease, yet the post-transcriptional regulators orchestrating these events are not yet completely understood. In this review, we analyse recent preclinical and clinical studies to dissect microRNA (miRNA)-mediated control of vascular endothelial biology. We describe how miR-181b-5p and miR-223 modulate NLRP3 inflammasome activation and pyroptosis, how miR-615-5p, miR-138, and miR-133a coordinate endothelial nitric oxide synthase (eNOS) activity and nitric oxide bioavailability, and how miR-33a/b, miR-150, and miR-342-3p influence lipid efflux and foam-cell formation in atherogenesis. We also discuss miRNA signatures that correlate with endothelial dysfunction in human cohorts. By integrating mechanistic pathways with emerging biomarker data, this study underscores the relevance of miRNAs as both diagnostic and potential targets in vascular diseases.
- 20 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 5919
Open AccessMicroRNA-Mediated Regulation of Vascular Endothelium: From Pro-Inflammation to Atherosclerosis
Endothelial inflammation and atherosclerosis remain leading drivers of cardiovascular disease, yet the post-transcriptional regulators orchestrating these events are not yet completely understood. In this review, we analyse recent preclinical and clinical studies to dissect microRNA (miRNA)-mediated control of vascular endothelial biology. We describe how miR-181b-5p and miR-223 modulate NLRP3 inflammasome activation and pyroptosis, how miR-615-5p, miR-138, and miR-133a coordinate endothelial nitric oxide synthase (eNOS) activity and nitric oxide bioavailability, and how miR-33a/b, miR-150, and miR-342-3p influence lipid efflux and foam-cell formation in atherogenesis. We also discuss miRNA signatures that correlate with endothelial dysfunction in human cohorts. By integrating mechanistic pathways with emerging biomarker data, this study underscores the relevance of miRNAs as both diagnostic and potential targets in vascular diseases.
- Open Access
- 17 February 2025
- Published by Taylor & Francis in Pulmonology
- Vol. 31 (1) , 2466924
The rise of old villains: the vaccination downfall worldwide
- 17 February 2025
- Published by Taylor & Francis in Pulmonology
- Vol. 31 (1) , 2466924
Open AccessThe rise of old villains: the vaccination downfall worldwide
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Fisioterapia e Pesquisa
- Vol. 32
The impact of an early, viable, and low-cost mobilization protocol in critically ill patients: comparison with conventional physical therapy
This study aims to analyze the outcomes of applying an early mobilization protocol, using low-cost interventions with the minimum necessary equipment in an intensive care unit. A clinical trial, controlled and randomized, conducted in collaboration with the Laboratory for Assessment and Research in Cardiorespiratory Performance of the Department of Physical Therapy at the Federal University of Minas Gerais and the Intensive Care Unit of Risoleta Tolentino Neves Hospital in Belo Horizonte, Brazil, over a period of 5 months. Patients were randomized into two groups (treatment n=67 and control n=67). The primary outcome was days of discharge from bed. Secondary outcomes included ICU length of stay, hospital length of stay, hospitalization costs, time on mechanical ventilation, ICU mortality, and hospital mortality. The group characteristics were similar in the initial assessment. It was found that 61 patients (97%) in the treatment group were discharged from bed compared to only two patients (3%) in the control group. The proposed mobilization protocol reduced hospitalization costs by 30.27%, an approximate difference of R$7,000.00 per patient. The mean ICU stay time for the treatment group was less than the control group. There were no statistically significant differences in ICU hours, hospital length of stay, or mechanical ventilation time. The results of this study demonstrated that the application of a low-cost and minimally equipped early mobilization protocol was safe and effective for patients, promoting early discharge from bed.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Fisioterapia e Pesquisa
- Vol. 32
Open AccessThe impact of an early, viable, and low-cost mobilization protocol in critically ill patients: comparison with conventional physical therapy
This study aims to analyze the outcomes of applying an early mobilization protocol, using low-cost interventions with the minimum necessary equipment in an intensive care unit. A clinical trial, controlled and randomized, conducted in collaboration with the Laboratory for Assessment and Research in Cardiorespiratory Performance of the Department of Physical Therapy at the Federal University of Minas Gerais and the Intensive Care Unit of Risoleta Tolentino Neves Hospital in Belo Horizonte, Brazil, over a period of 5 months. Patients were randomized into two groups (treatment n=67 and control n=67). The primary outcome was days of discharge from bed. Secondary outcomes included ICU length of stay, hospital length of stay, hospitalization costs, time on mechanical ventilation, ICU mortality, and hospital mortality. The group characteristics were similar in the initial assessment. It was found that 61 patients (97%) in the treatment group were discharged from bed compared to only two patients (3%) in the control group. The proposed mobilization protocol reduced hospitalization costs by 30.27%, an approximate difference of R$7,000.00 per patient. The mean ICU stay time for the treatment group was less than the control group. There were no statistically significant differences in ICU hours, hospital length of stay, or mechanical ventilation time. The results of this study demonstrated that the application of a low-cost and minimally equipped early mobilization protocol was safe and effective for patients, promoting early discharge from bed.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Fisioterapia e Pesquisa
- Vol. 32
O impacto de um protocolo de mobilização precoce, viável e de baixo custo em pacientes críticos: comparação com a fisioterapia convencional
RESUMO Neste estudo foi analisado o resultado da aplicação de um protocolo de mobilização precoce, fazendo uso de intervenções de baixo custo, com o mínimo de equipamentos necessários em uma unidade de terapia intensiva. Trata-se de um ensaio clínico, controlado e randomizado, realizado em parceria com o Laboratório de Avaliação e Pesquisa do Desempenho Cardiorrespiratório do Departamento de Fisioterapia da Universidade Federal de Minas Gerais e com a Unidade de Terapia Intensiva (UTI) do Hospital Risoleta Tolentino Neves, em Belo Horizonte, Brasil, no período de cinco meses. Os pacientes foram distribuídos de forma aleatória em dois grupos (tratamento [GT] n=67 e controle [CG] n=67). O desfecho primário foram os dias de saída do leito, enquanto os desfechos secundários foram: tempo de internação na UTI, tempo de internação hospitalar, custos de internação, tempo em Ventilação Mecânica Invasiva (VMI), mortalidade na UTI e mortalidade hospitalar. As características dos grupos foram similares na avaliação inicial. Verificou-se que 61 pacientes (97%) do GT foram retirados do leito, em comparação com apenas dois pacientes (3%) do GC. O protocolo de mobilização proposto reduziu os custos de internação em 30,27%, diferença aproximada de R$7 mil por paciente. A média de tempo de estadia na UTI do GT foi menor do que a do GC. Não houve diferença estatisticamente significativa quanto às horas de permanência em UTI, tempo de permanência hospitalar e tempo de VMI. A aplicação do protocolo de mobilização precoce de baixo custo e com o mínimo de equipamentos foi segura e eficaz para os pacientes, promovendo a saída precoce do leito.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Fisioterapia e Pesquisa
- Vol. 32
Open AccessO impacto de um protocolo de mobilização precoce, viável e de baixo custo em pacientes críticos: comparação com a fisioterapia convencional
RESUMO Neste estudo foi analisado o resultado da aplicação de um protocolo de mobilização precoce, fazendo uso de intervenções de baixo custo, com o mínimo de equipamentos necessários em uma unidade de terapia intensiva. Trata-se de um ensaio clínico, controlado e randomizado, realizado em parceria com o Laboratório de Avaliação e Pesquisa do Desempenho Cardiorrespiratório do Departamento de Fisioterapia da Universidade Federal de Minas Gerais e com a Unidade de Terapia Intensiva (UTI) do Hospital Risoleta Tolentino Neves, em Belo Horizonte, Brasil, no período de cinco meses. Os pacientes foram distribuídos de forma aleatória em dois grupos (tratamento [GT] n=67 e controle [CG] n=67). O desfecho primário foram os dias de saída do leito, enquanto os desfechos secundários foram: tempo de internação na UTI, tempo de internação hospitalar, custos de internação, tempo em Ventilação Mecânica Invasiva (VMI), mortalidade na UTI e mortalidade hospitalar. As características dos grupos foram similares na avaliação inicial. Verificou-se que 61 pacientes (97%) do GT foram retirados do leito, em comparação com apenas dois pacientes (3%) do GC. O protocolo de mobilização proposto reduziu os custos de internação em 30,27%, diferença aproximada de R$7 mil por paciente. A média de tempo de estadia na UTI do GT foi menor do que a do GC. Não houve diferença estatisticamente significativa quanto às horas de permanência em UTI, tempo de permanência hospitalar e tempo de VMI. A aplicação do protocolo de mobilização precoce de baixo custo e com o mínimo de equipamentos foi segura e eficaz para os pacientes, promovendo a saída precoce do leito.
- Open Access
- 9 January 2024
- Published by Elsevier in Vaccine: X
- Vol. 17, 100430
Overview of childhood vaccination coverage in Brazil and the impact of the COVID-19 pandemic: Is our children’s health at risk? A review of pre-COVID-19 periods and during the COVID-19 pandemic
- 9 January 2024
- Published by Elsevier in Vaccine: X
- Vol. 17, 100430
Open AccessOverview of childhood vaccination coverage in Brazil and the impact of the COVID-19 pandemic: Is our children’s health at risk? A review of pre-COVID-19 periods and during the COVID-19 pandemic
- Open Access
- 14 July 2023
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 19 (2) , 2234784
Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
Since the appearance of SARS-CoV-2, the scientific community has worked relentlessly to gather enough information about the illness caused by this virus infection. Such great effort has resulted in increased scientific publication, including phase 4 clinical trials addressing the applicability of COVID-19 vaccines. In those trials that investigated the properties of the vaccine among participants with morbidities, mainly immunocompromised individuals, the safety was recommended, but in the presence of immunogenicity, such protection was considered of short and medium terms. It was also observed that a physically active lifestyle might increase the immunogenicity of the COVID-19 vaccination in patients with autoimmune rheumatic diseases and in immunocompromised patients. The coadministration of different types of vaccine such as the combination of the recombinant adenovirus type 5 (AD5)-vectored Convidecia as heterologous reinforcement vs. CoronaVac with homologous reinforcement in adults previously vaccinated with CoronaVac, as well as the coadministration of inactivated COVID-19 vaccine followed by the administration of the tetravalent influenza vaccine (Fragmented, Inactivated) and the pneumococcal vaccine 23 presented satisfactory immunogenicity. However, the heterologous reinforcement had better immunogenicity when compared to the homologous reinforcement. Simultaneous COVID-19 vaccination and vaccines against seasonal influenza did not raise safety issues, producing acceptable levels of adverse reactions and preserving the antibody responses against SARS-CoV-2. In the lot-to-lot consistency evaluation, CoronaVac was seen to induce an immune response considered relatively high, and the lots presented a similar profile of stability and immunogenicity, thus enabling their large-scale distribution. In brief, this article addressed, mainly, the importance of evaluating the immunological response in the COVID-19 vaccination in patients with specific health conditions (e.g., immunocompromised individuals) aiming at enabling adjustments to the vaccine calendar in national vaccination programs.
- 14 July 2023
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 19 (2) , 2234784
Open AccessPhase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
Since the appearance of SARS-CoV-2, the scientific community has worked relentlessly to gather enough information about the illness caused by this virus infection. Such great effort has resulted in increased scientific publication, including phase 4 clinical trials addressing the applicability of COVID-19 vaccines. In those trials that investigated the properties of the vaccine among participants with morbidities, mainly immunocompromised individuals, the safety was recommended, but in the presence of immunogenicity, such protection was considered of short and medium terms. It was also observed that a physically active lifestyle might increase the immunogenicity of the COVID-19 vaccination in patients with autoimmune rheumatic diseases and in immunocompromised patients. The coadministration of different types of vaccine such as the combination of the recombinant adenovirus type 5 (AD5)-vectored Convidecia as heterologous reinforcement vs. CoronaVac with homologous reinforcement in adults previously vaccinated with CoronaVac, as well as the coadministration of inactivated COVID-19 vaccine followed by the administration of the tetravalent influenza vaccine (Fragmented, Inactivated) and the pneumococcal vaccine 23 presented satisfactory immunogenicity. However, the heterologous reinforcement had better immunogenicity when compared to the homologous reinforcement. Simultaneous COVID-19 vaccination and vaccines against seasonal influenza did not raise safety issues, producing acceptable levels of adverse reactions and preserving the antibody responses against SARS-CoV-2. In the lot-to-lot consistency evaluation, CoronaVac was seen to induce an immune response considered relatively high, and the lots presented a similar profile of stability and immunogenicity, thus enabling their large-scale distribution. In brief, this article addressed, mainly, the importance of evaluating the immunological response in the COVID-19 vaccination in patients with specific health conditions (e.g., immunocompromised individuals) aiming at enabling adjustments to the vaccine calendar in national vaccination programs.
- Open Access
- 1 January 2022
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 46, 339-347
Perfil funcional de pacientes com traumatismo cranioencefálico na alta hospitalar
The lesions caused by a Traumatic Brain Injury (TBI) of macro or micro character can physically and/or psychologically compromise an individual. Being a disease of modern society that affects any age, it is considered the main cause of morbidity and mortality in Brazil as it covers the economically active population. It can temporarily or permanently disable people, consequently generating an impact on their quality of life, and is difficult to measure their functional profile, level of recovery, and how long they will remain in a given profile. In order to determine and classify the functional profile of individuals with TBI at hospital discharge, an analytical, observational, and cross-sectional study was carried out in which the Glasgow Outcome Scale/Glasgow Extended Outcome Scale (GOSE) was applied through a form for data collection and interviews. The study population consisted of 26 volunteers, admitted for treatment at Hospital Universitario Sao Francisco de Braganca Paulista, Sao Paulo with a confirmed diagnosis of TBI through imaging tests between September 2019 and March 2020. We found evidence of 88.46 % belonging to the males, and 11.54% female, where the mean and standard deviation of age 35.73±16.76 were observed. Among the most common types of traumas, polytrauma stood out with 80.77% and GOSE had the highest scores where 46.15% had a score of 8. Most participants of the study were discharged from the HUSF with the functional profile of good recovery and may return to their lives before the trauma. Through functional classifications, it is possible to guide professionals responsible for the rehabilitation of those who were affected by trauma and were left with sequelae, as well as guide family members and community assistance centers. As lesões do Traumatismo Cranioencefálico (TCE) de caráter macro ou micro podem comprometer fisicamente e/ou psicologicamente o indivíduo. Sendo uma doença da sociedade moderna que acomete qualquer idade, é considerada principal causa de morbimortalidade no Brasil ao abranger a população economicamente ativa podendo incapacitar de forma temporária ou permanente, consequentemente gerando impacto na qualidade de vida, sendo difícil mensurar o perfil funcional, nível de recuperação e quanto tempo ficará em determinado perfil. Com o objetivo de determinar e classificar o perfil funcional de indivíduos com TCE na alta hospitalar, foi realizado um estudo analítico, observacional e transversal onde foi aplicado a Glasgow Outcome Scale/Escala de Resultado Ampliada de Glasgow (GOSE/ERGA) através de uma ficha para coleta de dados e entrevistas. A população do estudo foi constituída por 26 voluntários, admitidos para tratamento no Hospital Universitário São Francisco de Bragança Paulista-São Paulo com diagnóstico comprovado de TCE por meio de exames de imagem entre setembro/2019 e março de 2020. Encontramos evidências de 88,46% pertencente ao gênero masculino, e 11,54% gênero feminino, onde foram observados média e desvio padrão de idade 35,73±16,76. Entre os tipos de trauma mais comuns o politrauma se sobressaiu com 80,77% e a GOSE/ERGA teve maior indício com 46,15% de escore 8. A maioria dos colaboradores recebeu alta do HUSF com o perfil funcional de boa recuperação e poderão retornar a vida anterior ao trauma. Através das classificações funcionais pode-se orientar profissionais responsáveis pela reabilitação daqueles que foram acometidos pelo trauma e ficaram com sequelas, bem como orientar os familiares e centros de assistência a comunidade.
- 1 January 2022
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 46, 339-347
Open AccessPerfil funcional de pacientes com traumatismo cranioencefálico na alta hospitalar
The lesions caused by a Traumatic Brain Injury (TBI) of macro or micro character can physically and/or psychologically compromise an individual. Being a disease of modern society that affects any age, it is considered the main cause of morbidity and mortality in Brazil as it covers the economically active population. It can temporarily or permanently disable people, consequently generating an impact on their quality of life, and is difficult to measure their functional profile, level of recovery, and how long they will remain in a given profile. In order to determine and classify the functional profile of individuals with TBI at hospital discharge, an analytical, observational, and cross-sectional study was carried out in which the Glasgow Outcome Scale/Glasgow Extended Outcome Scale (GOSE) was applied through a form for data collection and interviews. The study population consisted of 26 volunteers, admitted for treatment at Hospital Universitario Sao Francisco de Braganca Paulista, Sao Paulo with a confirmed diagnosis of TBI through imaging tests between September 2019 and March 2020. We found evidence of 88.46 % belonging to the males, and 11.54% female, where the mean and standard deviation of age 35.73±16.76 were observed. Among the most common types of traumas, polytrauma stood out with 80.77% and GOSE had the highest scores where 46.15% had a score of 8. Most participants of the study were discharged from the HUSF with the functional profile of good recovery and may return to their lives before the trauma. Through functional classifications, it is possible to guide professionals responsible for the rehabilitation of those who were affected by trauma and were left with sequelae, as well as guide family members and community assistance centers. As lesões do Traumatismo Cranioencefálico (TCE) de caráter macro ou micro podem comprometer fisicamente e/ou psicologicamente o indivíduo. Sendo uma doença da sociedade moderna que acomete qualquer idade, é considerada principal causa de morbimortalidade no Brasil ao abranger a população economicamente ativa podendo incapacitar de forma temporária ou permanente, consequentemente gerando impacto na qualidade de vida, sendo difícil mensurar o perfil funcional, nível de recuperação e quanto tempo ficará em determinado perfil. Com o objetivo de determinar e classificar o perfil funcional de indivíduos com TCE na alta hospitalar, foi realizado um estudo analítico, observacional e transversal onde foi aplicado a Glasgow Outcome Scale/Escala de Resultado Ampliada de Glasgow (GOSE/ERGA) através de uma ficha para coleta de dados e entrevistas. A população do estudo foi constituída por 26 voluntários, admitidos para tratamento no Hospital Universitário São Francisco de Bragança Paulista-São Paulo com diagnóstico comprovado de TCE por meio de exames de imagem entre setembro/2019 e março de 2020. Encontramos evidências de 88,46% pertencente ao gênero masculino, e 11,54% gênero feminino, onde foram observados média e desvio padrão de idade 35,73±16,76. Entre os tipos de trauma mais comuns o politrauma se sobressaiu com 80,77% e a GOSE/ERGA teve maior indício com 46,15% de escore 8. A maioria dos colaboradores recebeu alta do HUSF com o perfil funcional de boa recuperação e poderão retornar a vida anterior ao trauma. Através das classificações funcionais pode-se orientar profissionais responsáveis pela reabilitação daqueles que foram acometidos pelo trauma e ficaram com sequelas, bem como orientar os familiares e centros de assistência a comunidade.